Information obtained in a number of experimental studies conducted over the last 40 years on the effects of lead on blood pressure is reviewed. Differences in animal species, age at beginning of exposure, level of lead exposure, indices of lead burden, and blood pressure effects of each study are reported. In several of the high-dose experiments, hypertension was observed, but nephrotoxicity of lead may have contributed to its development. Moreover, in other high-dose experiments, no hypertension was observed, and in at least one experiment, the evidence suggested that lead could reduce an elevated blood pressure. In contrast, the lower dose experiments consistently demonstrated a hypertensive effect. Overall, the data suggest a biphasic dose response. Establishment of an appropriate animal model to study blood pressure effects of lead will require careful assessment of dietary interactions with lead, unstressed blood pressure monitoring with standardized techniques, and documentation of biologically effective lead burden. Future research should examine lead exposure at more environmentally appropriate levels in order to deternine the validity of associating this pollutant with blood pressure effects in the human population.
Introduction
The literature reporting effects of lead exposure on blood pressure in experimental animals is scattered among international journals and proceedings over at least a 40-year period; in many cases, the authors' knowledge of similar or divergent experimental findings was not noted. It is not surprising that the results sometimes appear inconsistent. The purpose of this paper is to review these studies, examining the lead dose, route of exposure, age at initiation of exposure, when the effects were first observed, how long the animals were followed, and any indication of the internal lead burden. These findings will orient the reader to the papers in this issue, which discuss several possible targets of lead's cardiovascular toxicity.
An underlying question for most researchers is whether the lead dose administered should be of sufficient magnitude to induce nephrotoxicity prior to the onset of hypertension or if hypertension may develop prior to renal damage. Over the years, the experimental lead dose range for rats has varied between 70 mg per day (1, 2) (3) . Clearly, in the former case it is likely that renal pathology can be, observed, while in the latter, only subtle renal changes are observed.
The route of administration varies somewhat among studies, but it is usually oral (by gavage, in drinking water, or mixed in the food). The amount absorbed varies widely and depends on other nutritional factors and the age of the animal. The length of time for which exposure continues has been between 2 months and 2 years. The length of exposure before initiating monitoring and for continuation of monitoring varies greatly; in fact, some investigators have not followed a large enough group of control and experimental animals to detect statistical significance between the groups. Blood pressure monitoring is usually performed indirectly (by tail cuff plethysmography), either on the anesthetized or unanesthetized animal, or directly by insertion of an arterial catheter and detection by a pressure transducer. For repeated measurements in the same animal, the plethysmography is preferable but has the disadvantage that the animals are prewarmed, which is enough of a stress that some lead-exposed rats did not survive this procedure (4) . If the animals are unanesthetized, they must be conditioned to the restrainer so that unstressed values are obtained. Anesthetics also affect the blood pressure, so that this stress must also be evaluated. At the termination of the exposure period, it is quite helpful to have a direct blood pressure measurement to correlate with the indirect measurements previously obtained.
Species studied include rats, dogs, and pigeons. Sex of the animal may have a role in determining susceptibility to cardiovascular toxicity of lead, although this has not been clearly established. Animal housing and handling conditions are especially important if the animals are to be monitored in the unanesthetized, unstressed state. Indicators of the body burden of lead (such as blood or kidney lead concentrations) have frequently not been performed; if so, the extent of a doseresponse relationship between the amount of lead administered, blood lead, and blood pressure changes could be quantified. (8, 17) .
In another study, Evis et al. (4) administered lead (at 250 and 1000 ppm) to SHR and control rats. The authors evaluated a number of cardiovascular parameters including conscious and anesthetized blood pressure. The higher dose of lead significantly increased blood pressure in both groups of rats, which had reported blood lead concentrations of 40 ,ug/dL. Interestingly, lead accelerated the development of hypertension in the SHR animals and also increased their sensitivity to the warming required for dilation of the tail artery used for measuring conscious blood pressure (seven of eight animals died).
Results obtained in other species (pigeons and dogs) are summarized in Table 4 . In pigeons (19) , a low dose of lead (in combination with a number of other dietary parameters) produced a significant elevation in Inevitably, the dose range and shape of the doseresponse curve become issues for debate because they are relevant to the question of whether or not the lead exposure range is comparable to that of the general human population or only to those individuals occupationally exposed to lead. It appears from some experimental studies that the blood pressures measured at higher doses are lower than would be expected, suggesting a biphasic dose-response curve.
The exact dose-response range for this finding has not been well established, primarily because of different methodology used by each group of investigators. A standardized protocol for preparing and administering the lead dose, dietary components, rat strain, and age-at-initiation of exposure should be developed. Methodology for measuring blood pressure on a continuing basis in the conscious animal has improved so that tail cuff measurements can be performed without warming, and recordings can be obtained on several animals at once. These techniques should be applied in a carefully controlled setting along with validation of the biological markers of lead exposure.
Once these conditions have been well established, other important questions should be addressed. These include: Can the effect on adult blood pressure be established by an early exposure period at environmentally appropriate levels? Can the effect on blood pressure be reversed by removal of the lead source and reducing the lead burden? Answers to these questions would be valuable because they would help to evaluate the need to continue reductions in environmental lead exposure to the human population.
